Enhanced angiogenesis and growth of 12-lipoxygenase gene-transfected MCF-7 human breast cancer cells in athymic nude mice

Cancer Letters

Volumn 132, Issue 1-2, 1998, Pages 107-112

  Connolly, Jeanne M ^a   Rose, David P ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

12 Lipoxygenase; Angiogenesis; Apoptosis; Breast cancer; Cell proliferation; MCF 7 cells

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 12 LIPOXYGENASE; ESTROGEN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MCF 7; GENETIC TRANSFECTION; HUMAN CELL; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD31; ARACHIDONATE 12-LIPOXYGENASE; BREAST NEOPLASMS; CELL DIVISION; DNA FRAGMENTATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032561157     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00171-2     Document Type: Article

References (31)

1. Folkman J. What is the evidence that tumors are angiogenesis-dependent? J. Natl. Cancer Inst. 82:1990;4-6.
2. Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin. Diag. Path. 10:1993;302-313.
3. Heimann R., Ferguson D., Powers C., Recant W.M., Weichselbaum R.R., Hellman S. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J. Natl. Cancer Inst. 88:1996;1764-1769.
4. Fox S.B., Leek R.D., Bliss J., Mansi J.L., Gusterson B., Gatter K.C., Harris A.L. Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients. J. Natl. Cancer Inst. 89:1997;1044-1049.
5. Toi M., Hoshina S., Takayanagi T., Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn. J. Cancer Res. 85:1994;1045-1049.
6. Heffelfinger S.C., Yassin R., Miller M.A., Lower E. Vascularity of proliferative breast disease and carcinoma in situ correlates with histological features. Clin. Cancer Res. 2:1996;1873-1878.
7. Honn K.V., Tang D.G., Gao X., Butovich I.A., Liu B., Timar J. 12-Lipoxygenases and 12 (S)-HETE: role in cancer metastasis. Cancer Metastasis Rev. 13:1994;365-396.
8. Dethlefsen S.M., Shepro D., D'Amore P.A. Arachidonic acid metabolites in bFGF-, PDGF-, and serum-stimulated vascular cell growth. Exp. Cell Res. 212:1994;262-273.
9. Tang D.G., Renaud C., Stojakovic S., Diglio C.A., Porter A., Honn K.V. 12-(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis. Biochem. Biophys. Res. Commun. 211:1995;462-468.
10. Tang D.G., Chen Y.Q., Honn K.V. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;5241-5246.
11. Liu X.-H., Connolly J.M., Rose D.P. The 12-lipoxygenase gene-transfected MCF-7 human breast cancer cell line exhibits estrogen-independent, but estrogen and omega-6 fatty acid-stimulated proliferation in vitro, and enhanced growth in athymic nude mice. Cancer Lett. 109:1996;223-230.
12. Rose D.P., Hatala M.A., Connolly J.M., Rayburn J. Effect of diets containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice. Cancer Res. 53:1993;4686-4690.
13. Choudhuri R., Zhang H.-T., Donnini S., Ziche M., Bicknell R. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res. 57:1997;1814-1819.
14. Martin L., Green B., Renshaw C., Lowe D., Rudland P., Leinster S.L., Winstanley J. Examining the technique of angiogenesis assessment in invasive breast cancer. Br. J. Cancer. 76:1997;1046-1054.
15. Basolo F., Pollina L., Fontanini G., Fiore L., Pacini F., Baldanzi A. Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression. Br. J. Cancer. 75:1997;537-541.
16. Rose D.P., Connolly J.M. Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res. 50:1990;7139-7144.
17. D.P. Rose, J.M. Connolly, X.-H. Liu, Dietary fatty acids and human breast cancer cell growth, invasion and metastasis, in: E.K. Weisburger (Ed.), Diet and Breast Cancer, Plenum Press, New York, 1994, pp. 83-91.
18. Rose D.P., Connolly J.M., Liu X.-H. Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice, and the invasive capacity of these cell lines in vitro. Cancer Res. 54:1994;6557-6562.
19. Grammatikos S.I., Subbaiah P.V., Victor T.A., Miller W.M. N-3 and n-6 fatty acid processing and growth effects in neoplastic and non-cancerous human mammary epithelial cell lines. Br. J. Cancer. 70:1994;219-227.
20. Meyer J.S., Lee J.Y. Relationship of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival. Cancer Res. 40:1980;1890-1896.
21. Laroye G.J., Minkin S. The impact of mitotic index on predicting outcome in breast carcinoma: a comparison of different counting methods in patients with different lymph node status. Mod. Pathol. 4:1991;456-460.
22. Gaglia P., Bernadi A., Venesio T., Caldarola B., Lauro D., Cappa A.P., Calderini P., Liscia D.S. Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: its prognostic value on short-term recurrences. Eur. J. Cancer. 29A:1993;1509-1513.
23. Domagala W., Markiewski M., Harezga B., Dukowicz A., Osborn M. Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship to vimentin and p53 protein. Clin. Cancer Res. 2:1996;147-154.
24. Frankfurt O.S., Robb J.A., Sugarbaker E.V., Villa L. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases. Clin. Cancer Res. 3:1997;465-471.
25. Thomas K.A. Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem. 271:1996;603-606.
26. Connolly D.T., Heuvelman D.M., Nelson R., Olander J.V., Eppley B.L., Delfino J.J., Siegel N.R., Leimgruber R.M., Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84:1989;1470-1478.
27. Claffey K.P., Brown L.F., del Aguila L.F., Tognazzi K., Yeo K.-T., Manseau E.J., Dvorak H.F. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res. 56:1996;172-181.
28. Ohta Y., Watanabe Y., Murakami S., Oda M., Hayashi Y., Nonomura A., Endo Y., Sasaki T. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer. Br. J. Cancer. 76:1997;1041-1045.
29. Crew J.P., O'Brien T., Bradburn M., Fuggle S., Bicknell R., Cranston D., Harris A.L. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res. 57:1997;5281-5285.
30. Guidi A.J., Schnitt S.J., Fischer L., Tognazzi K., Harris J.R., Dvorak H.F., Brown L.F. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer. 80:1997;1945-1953.
31. Zhang H.-T., Craft P., Scott P.A.E., Ziche M., Weich H.A., Harris A.L., Bicknell R. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J. Natl. Cancer Inst. 87:1995;213-219.